Corteria Pharmaceuticals, a Paris, France-based biopharmaceutical company specialized in the development of therapies for unaddressed heart failure subpopulations, raised €65M in Series A funding.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,